A stick-on gel for plants could one day offer a simple, safe and targeted way to treat diseases and pests. Engineers at the ...
At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...
Johnson & Johnson is using artificial intelligence to slash by half the time it takes to generate new leads for developing ...
Inc., a Boston-based clinical-stage biotechnology company focused on antidepressants and anxiety drugs, is seeking to raise ...
Humana announced on Monday it will launch a pharmacy partnership with Mark Cuban's Cost Plus Drugs, with the health ...
After a surprising discovery that overcomes a longstanding problem in fiber optics, MIT researchers demonstrated a biomedical ...
Epic Systems was named to Time’s list of the most influential health and life sciences companies of 2026. The ranking, released April 27, is part of Time’s expanded TIME100 Companies franchise, which ...
Merck's Chief Information and Digital Officer Dave Williams explains how a $1 billion multi-year partnership with Google ...
With Phase 3 data in hand, Intellia Therapeutics is seeking approval for its in vivo CRISPR gene editing therapy for ...
Intellia Therapeutics Inc. said its gene-editing treatment for a rare swelling disorder met its goal in a late-stage trial, ...
MIT researchers discovered a paradoxical phenomenon in optical physics that could enable a new bioimaging method that's ...
As cell and gene therapy leaders gathered in Maryland to discuss accelerating clinical trials in children, one “cutting edge” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results